| Life-Science Firms Await Funding Details Small life-sciences companies in the U.S. will soon get details, expected to emerge in the next few days, of a federal program that will give a $1 billion boost to the industry. online.wsj.com |
Novo Nordisk, Greece Reach Drug Deal Novo Nordisk said it decided to resume sales of modern insulins in Greece after authorities there raised prices of these products to an "acceptable" level. online.wsj.com |
FDA, Clinical Trial Binary Events: Amarin, Amicus, Labopharm Mike Havrilla submits:Below are some Regulatory Catalyst Index updates for companies with recent FDA and clinical trial related news... Amarin Corp. (NASDAQ:AMRN) has a conference call scheduled for Tuesday 10-August at 11am (ET) and plans to provide an update on its financials and a progress update on the two ongoing pivotal Phase 3 studies (MARINE and ANCHOR) for AMR101 as a purified, prescription-grade omega-3 fatty acid compound that is being evaluated for the treatment of high triglycerides. Complete Story » seekingalpha.com |
Genzyme CEO Seeks Higher Offer Genzyme CEO Henri Termeer said the French pharmaceutical company Sanofi-Aventis would have to raise its $69-a-share offer if it wants to discuss the sale of the biotechnology company. online.wsj.com |
Sentara Wellness Payoff - Video Employee Healthcare Just Got Less Expensive: Sentara Healthcare Saves $3.4 Million & Improves Employee Health feedproxy.google.com |